The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 study of pritumumab in brain cancer.
 
Jose Arganda Carrillo
No Relationships to Disclose
 
Santosh Kesari
Leadership - Curtana
Stock and Other Ownership Interests - Curtana; Nascent Biotech
Consulting or Advisory Role - Biocept; Curtana; iCAD; Partner Therapeutics; xCures
Research Funding - Acrotech Biopharma; AIVITA Biomedical, Inc.; Bavarian Nordic; Biocept; Boehringer Ingelheim; Caris Life Sciences; Chimerix; CNS Pharmaceuticals; EIP Pharma; EpicentRx; iCAD; Novocure; Oblato; Orbus Therapeutics; Stemedica Cell Technologies; Tempus
 
Jaya Mini Gill
Stock and Other Ownership Interests - Nascent Biotech
Consulting or Advisory Role - Nascent Biotech
 
Charles Redfern
No Relationships to Disclose
 
Sean Carrick
Employment - Nascent Biotech
Leadership - Nascent Biotech
Stock and Other Ownership Interests - Nascent Biotech
Travel, Accommodations, Expenses - Nascent Biotech
 
Ivan Babic
Stock and Other Ownership Interests - Nascent Biotech
Consulting or Advisory Role - Nascent Biotech
Patents, Royalties, Other Intellectual Property - Nascent Biotech